NSE ScannerComparison · NSE · data 2026-11-01
Aarti Drugs Limited vs Unichem Laboratories Limited
In plain words
Size: Aarti Drugs Limited is about 1.2 times the market value of Unichem Laboratories Limited.
Valuation (P/E): Aarti Drugs Limited 20.8 vs Unichem Laboratories Limited 11.2.
Return on equity: Aarti Drugs Limited 13.4% vs Unichem Laboratories Limited 9.8%.
Debt to equity: Aarti Drugs Limited 0.37 vs Unichem Laboratories Limited 0.18.
Differences in the numbers, not a recommendation of either stock.
Side by side
| AARTIDRUGS | UNICHEMLAB | |
|---|---|---|
| Price | ₹435.2 | ₹483.75 |
| Market cap | ₹3,977 cr | ₹3,404 cr |
| P/E | 20.8 | 11.2 |
| P/B | — | — |
| ROE | 13.4% | 9.8% |
| ROCE | 13.2% | -0.5% |
| Debt / equity | 0.37 | 0.18 |
| Operating margin | 9.8% | 4.6% |
| Dividend yield | 0.46% | 0.00% |
| Sales growth, 3 years (yearly) | -2.0% | 18.1% |
| Profit growth, 3 years (yearly) | 5.4% | — |
| 1-year return | -12.1% | 3.4% |
| Revenue, last 12 months | ₹2,678 cr | ₹2,308 cr |
| Net profit, last 12 months | ₹191 cr | ₹305 cr |
| Latest quarter | Jun 2026 | Jun 2026 |
| Quarter net profit | ₹50 cr | ₹41 cr |
| Quarter profit vs a year earlier | -6.9% | — |
| Promoter holding | 54.07% | 70.22% |
| Health check | Average (6/10) | Strong (7/10) |
Common questions
Which has a higher P/E, Aarti Drugs Limited or Unichem Laboratories Limited?
Aarti Drugs Limited trades at the higher P/E (20.8 against 11.2). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Aarti Drugs Limited (13.4% against 9.8%).
Which carries more debt?
Aarti Drugs Limited has the higher debt-to-equity ratio (0.37 against 0.18).